Breakthrough's comment on the announcement of a review of co-payments in the NHS

Jeremy Hughes, Chief Executive of Breakthrough Breast Cancer, says:

“Today’s announcement to review the policy on co-payments in the NHS is welcome news and should provide much needed clarity on this complex issue.

“Breakthrough Breast Cancer believes that access to treatments should be based on clinical need and not cost. We look forward to hearing more about the proposed review and final report due in October.”